You are here: All Products  > BeiGene’s Phase III Data Shows PD-1 Effective as First Line Therapy for Esophageal Carcinoma

BeiGene’s Phase III Data Shows PD-1 Effective as First Line Therapy for Esophageal Carcinoma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.